{
  "$schema": "folio-library-entry/v1",
  "id": "10665-205022",
  "blocks": [
    {
      "id": "library/10665-205022/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 3,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "SEA-HLM-390 \nDistribution: General \nEnumeration of CD4 T \nLymphocytes \nReport of a Workshop \nBangkok, Thailand, 6-10 June 2006 \nWHO Project: ICP BCT 001 \n \n \n© World Health Organization \nThis document is not a formal publication of the World Health Organization \n(WHO), and all rights are reserved by the Organization. The document may, \nhowever, be freely reviewed, abstracted, reproduced or translated, in part or in \nwhole, but not for sale or for use in conjunction with commercial purposes. \nThe views expressed in documents by named authors are solely the \nresponsibility of those authors. \nSep",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The title and copyright page of a 2006 WHO South-East Asia workshop report on enumeration of CD4 T lymphocytes held in Bangkok.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page",
      "pageStart": 3,
      "pageEnd": 5,
      "target": "../sections/sec-000-page.md",
      "narrative": null,
      "content": "CONTENTS \nPage \n1. Introduction ....................................................................................................... 1 \n2. Objectives .......................................................................................................... 2 \n3. Inaugural session................................................................................................. 2 \n4. Proceedings of the meeting................................................................................. 3 \n4.1 \nCountry reports .................................................................................",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The table of contents of the CD4 T lymphocyte enumeration workshop report, listing its sections and annexes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduction",
      "pageStart": 5,
      "pageEnd": 6,
      "target": "../sections/sec-001-1-introduction.md",
      "narrative": null,
      "content": "Introduction \nThe AIDS epidemic continues to spread across the South-East Asia (SEA) \nRegion, which is the most affected part of the world after sub-Saharan Africa. \nTo date, around 40 million people around the world have been infected with \nthe human immunodeficiency virus (HIV), the virus that causes AIDS. Of them \nmore than six million are in the SEA Region. \nThe “3 by 5” initiative has stimulated Member States to accelerate and \nstrengthen mechanisms for providing antiretroviral therapy (ART) to needy \npeople living with HIV. The availability of economical generic drugs has \nfurther booste",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the Bangkok workshop on CD4 T lymphocyte counting, citing the HIV burden in the South-East Asia Region and the need for CD4 testing to guide antiretroviral therapy. It notes that sixteen laboratory professionals from seven countries attended, facilitated by Siriraj Hospital and India's National AIDS Research Institute.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Objectives",
      "pageStart": 6,
      "pageEnd": 6,
      "target": "../sections/sec-002-2-objectives.md",
      "narrative": null,
      "content": "Objectives \nThe objectives of the workshop were to: \n(1) Review the status of enumeration of CD4 T lymphocytes in high \nHIV-burden Member countries of the SEA Region; \n(2) Orient on new, economical and field-friendly technologies for CD4 \nenumeration; \n(3) Provide hands-on training on selected technologies including the \ninterpretation of results, and \n(4) Identify a mechanism for external quality assessment scheme.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists the workshop's four objectives, from reviewing CD4 enumeration status to hands-on training and planning external quality assessment.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Inaugural session",
      "pageStart": 6,
      "pageEnd": 7,
      "target": "../sections/sec-003-3-inaugural-session.md",
      "narrative": null,
      "content": "Inaugural session \nThe Dean of the medical faculty at Siriraj Hospital welcomed the participants. \nIn his inaugural remarks, he emphasized that CD4 enumeration technology is \ncritical for effective implementation of any programme on antiretroviral \ntherapy as well as for providing efficient care to the patient. \nActing WHO Representative, Thailand read the inaugural address of Dr \nSamlee Plianbangchang, Regional Director, WHO South-East Asia (SEA) \nRegion. In his inaugural address, Dr Samlee said that the Millennium \nDevelopment Goals (MDGs) have identified HIV as a disease of global \nimportan",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarizes the opening of the CD4 workshop, where speakers stressed the importance of CD4 counts for antiretroviral treatment and of quality assurance. Participants were encouraged to learn about the various technologies so they could choose one suited to their infrastructure and resources.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Proceedings of the meeting",
      "pageStart": 7,
      "pageEnd": 7,
      "target": "../sections/sec-004-4-proceedings-of-the-meeting.md",
      "narrative": null,
      "content": "Proceedings of the meeting",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A heading introducing the proceedings of the meeting.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Country reports",
      "pageStart": 7,
      "pageEnd": 11,
      "target": "../sections/sec-005-41-country-reports.md",
      "narrative": null,
      "content": "existing capacity of the countries; presentations and discussions to disseminate \nnew information; group work to formulate a generic plan for establishment of \nexternal quality assessment scheme and hands-on experience in various \ntechnologies to enumerate CD4 T lymphocytes. \n4.1 \nCountry reports \nBangladesh \nBangladesh faces many risk factors for HIV infection but the burden of \nHIV/AIDS in the country is minimal. The first HIV case was reported in 1989 \nand the number of people living with HIV infection in 2006 was about 700. \nRecent national surveillance indicated a high prevalence (>4%) of",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Outlines the workshop's working methods and then reports on the status of CD4 T lymphocyte enumeration in participating countries such as Bangladesh, India, Indonesia, Myanmar, Nepal, Sri Lanka and Thailand. The country reports cover available equipment, laboratories performing counts, training and participation in quality assessment schemes. Thailand's report notes training courses run by Siriraj Hospital's centre of excellence and a national institute since 2004.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Presentations and topics for discussions",
      "pageStart": 11,
      "pageEnd": 15,
      "target": "../sections/sec-006-42-presentations-and-topics-for-discussions.md",
      "narrative": null,
      "content": "Presentations and topics for discussions \nRole of CD4 count in HIV infection \nDr Ramesh Paranjape, Director, National AIDS Research Institute (NARI), \nPune, India, discussed the immunopathogenesis of HIV infection and the role \nof CD4 count estimation in HIV infection. He gave an account of the infection \nof CD4+ T cells by HIV and the co-receptor usage of HIV for entry in the cell. \nHe elaborated the clinical course of HIV infection, different patterns of HIV \ndisease progression and mechanisms of CD4 + T cell depletion in HIV \ninfection. Dr Paranjape also explained about the use of CD4 count",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarizes the technical presentations at the workshop, beginning with the role of CD4 counts in HIV pathogenesis, disease monitoring and decisions on starting antiretroviral therapy. Further talks explain flow cytometry principles, gating strategies such as panleucogating, low-cost and alternative counting methods, and haematology analysers. It concludes that the choice of method should depend on test volume, staff, support and cost, with validation and proficiency testing before routine use.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Group work",
      "pageStart": 15,
      "pageEnd": 15,
      "target": "../sections/sec-007-43-group-work.md",
      "narrative": null,
      "content": "Group work \nParticipants developed a generic plan for the establishment of a national \nexternal quality assessment scheme for CD4 T lymphocytes enumeration. The \ndraft plan emphasized on responsibility of the National Programme Officer to \ninstitutionalize national EQAS, development of infrastructure for EQAS, \ntraining of human resource, logistics for shipment of material with or without \nstabilizers, continuous collaboration between the organizer of the scheme as \nwell as the participating units and a continuing endeavour towards quality \nimprovement.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes a generic plan drafted by participants for a national external quality assessment scheme for CD4 counting, covering responsibilities, infrastructure, training and specimen logistics.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Hands-on enumeration of CD4 T Lymphocytes",
      "pageStart": 15,
      "pageEnd": 16,
      "target": "../sections/sec-008-44-hands-on-enumeration-of-cd4-t-lymphocytes.md",
      "narrative": null,
      "content": "Hands-on enumeration of CD4 T Lymphocytes \nAll participants were demonstrated flow cytometry techniques using \nFACSCount and Tritest on FACSCalibur. The tests were also performed by the \nReport of a Workshop \nPage 12 \nparticipants themselves. The facilitators discussed various issues, commonly \nencountered problems and ways to obviate these. \nAn open session was organized with the participants on the last day of \nthe workshop. All subjects that were discussed at the workshop were \nreviewed. Country-specific issues were also discussed and possible solutions \nto improve laboratory support to ART",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes that participants were shown and performed flow cytometric CD4 counting and that a final open session reviewed topics and country-specific issues.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Recommendations",
      "pageStart": 16,
      "pageEnd": 16,
      "target": "../sections/sec-009-5-recommendations.md",
      "narrative": null,
      "content": "Recommendations",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A heading introducing the workshop's recommendations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "For WHO",
      "pageStart": 16,
      "pageEnd": 16,
      "target": "../sections/sec-010-51-for-who.md",
      "narrative": null,
      "content": "For WHO \nThe following actions were recommended for WHO:  \n(1) WHO should develop guidelines and standard operating procedure \nfor CD4 T lymphocytes enumeration. \n(2) WHO should support the expansion of Regional CD4 T \nlymphocytes EQAS to Sri Lanka, Myanmar, and Nepal in addition to \nIndia, Indonesia and Thailand where it is already in operation. \n(3) WHO should develop criteria for clinical application of CD4 counts \nin paediatric population.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists recommendations for WHO, including guidelines and procedures for CD4 enumeration, expansion of the regional quality scheme and criteria for paediatric use.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "For Member States",
      "pageStart": 16,
      "pageEnd": 17,
      "target": "../sections/sec-011-52-for-member-states.md",
      "narrative": null,
      "content": "For Member States \nThe following were recommended for Member countries:  \n(1) Member countries should accord priority to establish infrastructure \nfor CD4 T lymphocytes enumeration to provide effective support to \nART programmes. \n(2) Member countries should initiate a national EQAS for CD4 T \nlymphocytes and selected laboratories should participate in WHO \nRegional EQAS. \nEnumeration of CD4 T Lymphocytes \nPage 13 \n(3) Member countries should conduct studies to ascertain the baseline \ndata of CD4 T lymphocytes in normal population to develop \nrealistic country-specific cut off values for initi",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists recommendations for Member countries on CD4 testing infrastructure, joining the regional quality scheme, establishing local baseline values and equipment maintenance.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Concluding session",
      "pageStart": 17,
      "pageEnd": 18,
      "target": "../sections/sec-012-6-concluding-session.md",
      "narrative": null,
      "content": "Concluding session \nWHO’s initiative in organizing this meeting was appreciated in the concluding \nsession. The participants also felt that the deliberations shall go a long way in \ndeveloping or improving the laboratory support to ART programmes. The \nmeeting ended with a vote of thanks to officials who managed the meeting. \nDr Rajesh Bhatia thanked the local organizers, Siriraj Hospital and the Ministry \nof Public Health, Thailand, for the conduct of this workshop. He also thanked \nthe facilitators, local organizers as well as international experts who facilitated \nthe workshop with their va",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the closing session, where participants valued the meeting and WHO staff thanked the Thai hosts and facilitators.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "List of participants",
      "pageStart": 18,
      "pageEnd": 20,
      "target": "../sections/sec-013-1-list-of-participants.md",
      "narrative": null,
      "content": "Bangladesh \nDr Benazir Ahmed \nSenior Scientific Officer \nInstitute of Epidemiology \nDisease Control & Research (IEDCR) \nMohakhali, Dhaka \nTel. 88 0189454279; 88 028253977 \nE-mail: dbenazirahmed@yahoo.com \nDr Mahbub Iqbal \nIn-charge of ARV, Institute of Public Health \nMohakhali, Dhaka \nTel. 88 029898525 (office) \n       88 029890944 (Res) \nIndia \nDr Charoo Hans \nSr Microbiologist and HoD \nDr Ram Manohar Lohia Hospital \nNew Delhi \nTel. 91 11 23404309 (Office) \n 91 11 23383131 (Res) \n 98 11 019828 (mobile) \nE-mail: charoohans@yahoo.co.uk \nDr B.L. Sherwal \nProfessor, Department of Microbiology \nLa",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 1, the list of workshop participants, facilitators and WHO secretariat with their affiliations and contact details.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-205022/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Programme",
      "pageStart": 20,
      "pageEnd": 21,
      "target": "../sections/sec-014-2-programme.md",
      "narrative": null,
      "content": "Tuesday, 6 June 2006 \nRegistration \nInauguration \nObjectives \n0800 – 0930 \nMechanism \nPre-workshop test \n0930 – 1015 \nOverview of HIV, ART and CD4 \nenumeration \nDr Kovit \n1015 – 1230 \nCountry Reports \nModerator: \nDr Rajesh Bhatia \n1330 – 1430 \nRole of CD4 count:  \nDiscussions \n \n1430 – 1530 \nPrinciples of Flow cytometry and recent \nadvances in its improvements \nDr Kovit \n1530 – 1700 \nLow cost technologies to enumerate CD4 \nand their use in SEAR countries \nDr Madhuri Thakkar \nWednesday, 7 June 2006 \n0830 – 0930 \nGating strategies and selection of reagents \nrelated to subset counting \nDr Kovit",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 2, the day-by-day programme of the CD4 enumeration workshop, listing sessions, times and facilitators.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
